Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes

Purpose: To investigate the outcome of primary idiopathic extra-large full-thickness macular holes (FTMH) treated with a modified autologous neurosensory retinal transplantation (ART) adjuncted by bevacizumab (BCZ) injection. Methods: In this retrospective interventional case series, five consecutiv...

Full description

Saved in:
Bibliographic Details
Main Authors: Hossein Ashraf, Sezaneh Haghpanah, Mohammad Hossein Nowroozzadeh
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993625000222
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856736150224896
author Hossein Ashraf
Sezaneh Haghpanah
Mohammad Hossein Nowroozzadeh
author_facet Hossein Ashraf
Sezaneh Haghpanah
Mohammad Hossein Nowroozzadeh
author_sort Hossein Ashraf
collection DOAJ
description Purpose: To investigate the outcome of primary idiopathic extra-large full-thickness macular holes (FTMH) treated with a modified autologous neurosensory retinal transplantation (ART) adjuncted by bevacizumab (BCZ) injection. Methods: In this retrospective interventional case series, five consecutive patients with primary extra-large chronic FTMHs were investigated. The ART procedure included internal limiting membrane (ILM) peeling of both donor and macular hole (MH) areas, placement of the harvested tissue under the edges of MH and use of silicone oil tamponade. Results: The median age was 64 (60–77) years. The first patient developed choroidal neovascularization one month after surgery, which was treated with BCZ injections. Subsequent patients received injection of BCZ (1.25 mg/0.05 mL) into the silicone oil at the end of the initial surgery. At the last follow-up, complete anatomical closure of the MH was achieved in all patients. With the exception of the first patient, all other patients achieved either a final ellipsoid zone (EZ) defect of zero (three cases) or a reduction to 100 μm (one case). The external limiting membrane (ELM) was completely reconstructed in all of patients. All patients demonstrated an improvement in best corrected distant visual acuity (BCDVA) one month after ART surgery, which was sustained throughout the follow-up period (12–42 months). The median LogMAR BCDVA at baseline was 1.4 (1.3–1.4) which decreased to 1.1(1.0–1.1) (P = 0.041) at the first month and 1.0 (0.7–1.2) (P = 0.043) at the last follow-up. Conclusions: The use of ART surgery accompanied by BCZ injection appears to be an effective method for primary extra-large chronic FTMHs.
format Article
id doaj-art-54e434c7754541119cf9bf0cc28b7219
institution Kabale University
issn 2451-9936
language English
publishDate 2025-06-01
publisher Elsevier
record_format Article
series American Journal of Ophthalmology Case Reports
spelling doaj-art-54e434c7754541119cf9bf0cc28b72192025-02-12T05:31:29ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362025-06-0138102269Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holesHossein Ashraf0Sezaneh Haghpanah1Mohammad Hossein Nowroozzadeh2Poostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Ophthalmology Department, Khalili Hospital, Shiraz University of Medical Sciences, Shiraz, Iran; Corresponding author. Poostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, IranPoostchi Ophthalmology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran; Ophthalmology Department, Khalili Hospital, Shiraz University of Medical Sciences, Shiraz, IranPurpose: To investigate the outcome of primary idiopathic extra-large full-thickness macular holes (FTMH) treated with a modified autologous neurosensory retinal transplantation (ART) adjuncted by bevacizumab (BCZ) injection. Methods: In this retrospective interventional case series, five consecutive patients with primary extra-large chronic FTMHs were investigated. The ART procedure included internal limiting membrane (ILM) peeling of both donor and macular hole (MH) areas, placement of the harvested tissue under the edges of MH and use of silicone oil tamponade. Results: The median age was 64 (60–77) years. The first patient developed choroidal neovascularization one month after surgery, which was treated with BCZ injections. Subsequent patients received injection of BCZ (1.25 mg/0.05 mL) into the silicone oil at the end of the initial surgery. At the last follow-up, complete anatomical closure of the MH was achieved in all patients. With the exception of the first patient, all other patients achieved either a final ellipsoid zone (EZ) defect of zero (three cases) or a reduction to 100 μm (one case). The external limiting membrane (ELM) was completely reconstructed in all of patients. All patients demonstrated an improvement in best corrected distant visual acuity (BCDVA) one month after ART surgery, which was sustained throughout the follow-up period (12–42 months). The median LogMAR BCDVA at baseline was 1.4 (1.3–1.4) which decreased to 1.1(1.0–1.1) (P = 0.041) at the first month and 1.0 (0.7–1.2) (P = 0.043) at the last follow-up. Conclusions: The use of ART surgery accompanied by BCZ injection appears to be an effective method for primary extra-large chronic FTMHs.http://www.sciencedirect.com/science/article/pii/S2451993625000222Autologous retinal graftAutologous retinal transplantationBevacizumabMacular holeRetinal autograft
spellingShingle Hossein Ashraf
Sezaneh Haghpanah
Mohammad Hossein Nowroozzadeh
Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
American Journal of Ophthalmology Case Reports
Autologous retinal graft
Autologous retinal transplantation
Bevacizumab
Macular hole
Retinal autograft
title Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
title_full Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
title_fullStr Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
title_full_unstemmed Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
title_short Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
title_sort modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra large chronic macular holes
topic Autologous retinal graft
Autologous retinal transplantation
Bevacizumab
Macular hole
Retinal autograft
url http://www.sciencedirect.com/science/article/pii/S2451993625000222
work_keys_str_mv AT hosseinashraf modifiedautologousneurosensoryretinaltransplantationandbevacizumabinjectioninprimaryextralargechronicmacularholes
AT sezanehhaghpanah modifiedautologousneurosensoryretinaltransplantationandbevacizumabinjectioninprimaryextralargechronicmacularholes
AT mohammadhosseinnowroozzadeh modifiedautologousneurosensoryretinaltransplantationandbevacizumabinjectioninprimaryextralargechronicmacularholes